BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20425429)

  • 1. Application of immunotherapy in pediatric leukemia.
    Wayne AS
    Curr Hematol Malig Rep; 2009 Jul; 4(3):159-66. PubMed ID: 20425429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease.
    Chang YJ; Zhao XY; Huang XJ
    Front Immunol; 2018; 9():3041. PubMed ID: 30619371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of leukemia relapse after allogeneic hematopoietic stem cell transplantation: integrating transplantation with genetically modified T cell therapies.
    Dotti G
    Curr Opin Hematol; 2015 Nov; 22(6):489-96. PubMed ID: 26335421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
    Bertaina A; Roncarolo MG
    Front Immunol; 2019; 10():1342. PubMed ID: 31354695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells.
    Troeger A; Meisel R; Moritz T; Dilloo D
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S59-64. PubMed ID: 15812533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
    Fowler DH; Gress RE
    Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation.
    Schetelig J; Kiani A; Schmitz M; Ehninger G; Bornhäuser M
    Cancer Immunol Immunother; 2005 Nov; 54(11):1043-58. PubMed ID: 15887014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2010 Dec; 57(4):253-347. PubMed ID: 21183421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell therapy of leukemia.
    Riddell SR; Murata M; Bryant S; Warren EH
    Cancer Control; 2002; 9(2):114-22. PubMed ID: 11965232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation leukemia immunotherapy.
    Vincent K; Roy DC; Perreault C
    Blood; 2011 Sep; 118(11):2951-9. PubMed ID: 21734234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
    Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive immunotherapy, chemotherapy, and second allogeneic transplant in the treatment of post-transplant relapse of acute leukemia in children: a single center experience.
    Formankova R; Sedlacek P; Keslová P; Sramkova L; Zizkova H; Stary J
    Leuk Lymphoma; 2010 Oct; 51(10):1936-40. PubMed ID: 20846093
    [No Abstract]   [Full Text] [Related]  

  • 13. Introducing graft-versus-leukemia into autologous stem cell transplantation.
    Klingemann HG
    J Hematother; 1995 Aug; 4(4):261-7. PubMed ID: 7489140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Immune Checkpoints after Cellular Therapy.
    Schmitz F; Wolf D; Holderried TAW
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies.
    Dellabona P; Casorati G; de Lalla C; Montagna D; Locatelli F
    Clin Immunol; 2011 Aug; 140(2):152-9. PubMed ID: 21185785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of chimeric antigen receptor T cells in allogeneic hematopoietic stem cell transplantation.
    Liu J; Zhang X; Zhong JF; Zhang C
    Immunotherapy; 2019 Jan; 11(1):37-44. PubMed ID: 30702011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft versus leukemia reactivity after allogeneic stem cell transplantation.
    Falkenburg JH; Warren EH
    Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S33-8. PubMed ID: 21195308
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel transplant strategies for generating graft-versus-leukemia effect in acute myeloid leukemia.
    Parmar S; Fernandez-Vina M; de Lima M
    Curr Opin Hematol; 2011 Mar; 18(2):98-104. PubMed ID: 21245756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-versus-leukemia reactions in allogeneic chimeras.
    Kolb HJ; Schmid C; Barrett AJ; Schendel DJ
    Blood; 2004 Feb; 103(3):767-76. PubMed ID: 12958064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-leukemia effects of transplantation and donor lymphocytes.
    Kolb HJ
    Blood; 2008 Dec; 112(12):4371-83. PubMed ID: 19029455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.